• Combined Lung Cancer Diagnostic Services, Concord & Royal Prince Alfred Hospitals • International leaders in interventional and diagnostic bronchoscopy • Collaborative and comprehensive lung cancer evaluation • Integration of cutting-edge technology, innovation, research and clinical care
Headquarters:
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2024 (2 years)
Address:
null
LOW
spending power